Specifically, treatment of genetically engineered mice harboring the Mdm2SNP309G allele with the mutagen AOM led to increased expression of Mdm2, estrogen receptor α (ERα), and Sp1 in colon tissue compared to WT mice (Mdm2SNP309T), but there were no differences in p53 stabilization. This evidence concerns the gene ESR1 and infectious otitis media.